BIOMAT Database Logo BIOMAT Database Logo

Antibody-coated bacteria as an indicator of the site of urinary tract infection in renal transplant recipients receiving immunosuppressive agents. 1977

D F Keren, and S D Nightingale, and C L Hamilton, and P Charache, and W G Walker

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001437 Bacteriuria The presence of bacteria in the urine which is normally bacteria-free. These bacteria are from the URINARY TRACT and are not contaminants of the surrounding tissues. Bacteriuria can be symptomatic or asymptomatic. Significant bacteriuria is an indicator of urinary tract infection. Bacteriurias
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

D F Keren, and S D Nightingale, and C L Hamilton, and P Charache, and W G Walker
Antibody-coated bacteria in urinary tract infection.
August 1975, Kidney international. Supplement,
D F Keren, and S D Nightingale, and C L Hamilton, and P Charache, and W G Walker
Antibody-coated bacteria in the urine and the site of urinary-tract infection.
March 1974, The New England journal of medicine,
D F Keren, and S D Nightingale, and C L Hamilton, and P Charache, and W G Walker
Antibody-coated bacteria and urinary tract infection.
March 1979, The Journal of pediatrics,
D F Keren, and S D Nightingale, and C L Hamilton, and P Charache, and W G Walker
Urinary tract infection in renal transplant recipients.
October 2008, European journal of clinical investigation,
D F Keren, and S D Nightingale, and C L Hamilton, and P Charache, and W G Walker
Usefulness of the antibody-coated bacteria assay in the management of urinary tract infection in the renal transplant patient.
January 1979, Transplantation,
D F Keren, and S D Nightingale, and C L Hamilton, and P Charache, and W G Walker
[Urinary tract infection : clinical significance of antibody-coated bacteria].
April 1984, Hinyokika kiyo. Acta urologica Japonica,
D F Keren, and S D Nightingale, and C L Hamilton, and P Charache, and W G Walker
[Antibody-coated bacteria and localization of urinary tract infection].
October 1977, Schweizerische medizinische Wochenschrift,
D F Keren, and S D Nightingale, and C L Hamilton, and P Charache, and W G Walker
Localization of urinary tract infection by antibody-coated bacteria.
October 1984, The Journal of the Association of Physicians of India,
D F Keren, and S D Nightingale, and C L Hamilton, and P Charache, and W G Walker
Urinary Tract Infection among Renal Transplant Recipients in Yemen.
January 2015, PloS one,
D F Keren, and S D Nightingale, and C L Hamilton, and P Charache, and W G Walker
Pharmacoeconomics of immunosuppressive agents in renal transplant recipients.
May 1999, Transplantation proceedings,
Copied contents to your clipboard!